Liang Liao

3PUBLICATIONS
2CO-AUTHORS
Innate immunityPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 21, 2026
Isobavachin inhibits osteoclastogenesis in inflammatory osteolysis loss by modulating the ROS-mediated Nrf2/HO-1 signaling pathway.

|May 21, 2020
Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironment.

Min Mao, Qingliang Yu, Rongzhi Huang

|Aug 09, 2019
Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta-analysis and systematic review.

Qingliang Yu, Jiayi Xie, Jiangmiao Li

Pageof 1

Frequent Collaborators

2 joint publications

Qingliang Yu

1 joint publications

Zhen Wang